![BIIB - Biogen Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=BIIB&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 30.75B | EPS (ttm) | 8.01 |
P/E | 26.38 | EPS this Y | 5.96% |
Forward P/E | 12.21 | EPS next Y | 10.90% |
PEG | 6.68 | EPS past 5Y | -18.05% |
P/S | 3.31 | EPS next 5Y | 3.95% |
P/B | 2.02 | EPS Q/Q | 0.93% |
Dividend | - | Sales Q/Q | -5.62% |
Insider Own | 0.77% | Inst Own | 89.51% |
Insider Trans | -0.09% | Inst Trans | 0.82% |
Short Float | 2.51% | Earnings | Aug 01/b |
Analyst Recom | 1.67 | Target Price | 280.90 |
Avg Volume | 1.03M | 52W Range | 189.44 - 278.95 |
|
|
|
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Keeney Adam | Head of Corporate Development | May 01 '24 | Option Exercise | 0.00 | 938 | 0 | 938 | May 03 08:00 PM | Singhal Priya | Head of Development | Apr 02 '24 | Sale | 213.09 | 93 | 19,817 | 4,886 | Apr 03 08:24 PM | Murphy Nicole | Head of Pharm Ops and Tech | Apr 01 '24 | Option Exercise | 0.00 | 240 | 0 | 9,751 | Apr 03 08:11 PM | Singhal Priya | Head of Development | Feb 22 '24 | Sale | 221.23 | 262 | 57,962 | 4,886 | Feb 26 07:54 PM | Singhal Priya | Head of Development | Feb 16 '24 | Option Exercise | 0.00 | 1,208 | 0 | 5,429 | Feb 21 09:27 PM |
|
|
![](gfx/nic2x2.gif) |
![OMIC - Singular Genomics Systems Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=OMIC&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 19.50M | EPS (ttm) | -39.39 |
P/E | - | EPS this Y | 8.54% |
Forward P/E | - | EPS next Y | 11.13% |
PEG | - | EPS past 5Y | -64.52% |
P/S | 7.83 | EPS next 5Y | 11.10% |
P/B | 0.12 | EPS Q/Q | -3.02% |
Dividend | - | Sales Q/Q | -48.78% |
Insider Own | 42.70% | Inst Own | 25.74% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.87% | Earnings | May 14/a |
Analyst Recom | 2.00 | Target Price | 6.50 |
Avg Volume | 5.91K | 52W Range | 7.50 - 27.60 |
|
|
|
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Spaventa Andrew | Chief Executive Officer | Nov 17 '23 | Buy | 0.42 | 75,000 | 31,755 | 4,061,206 | Nov 20 04:31 PM | Glezer Eli N. | Chief Scientific Officer | Nov 16 '23 | Buy | 0.43 | 200,000 | 85,640 | 4,570,000 | Nov 20 04:30 PM | Spaventa Andrew | Chief Executive Officer | Nov 16 '23 | Buy | 0.41 | 43,468 | 17,857 | 3,986,206 | Nov 20 04:31 PM | Kamdar Kim P. | Director | Aug 15 '23 | Sale | 0.53 | 200,000 | 106,960 | 3,763,985 | Aug 15 07:17 PM | Kamdar Kim P. | Director | Aug 14 '23 | Sale | 0.57 | 77,991 | 44,424 | 3,963,985 | Aug 15 07:17 PM |
|
|
![](gfx/nic2x2.gif) |
![GTI - Graphjet Technology - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=GTI&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 466.63M | EPS (ttm) | 0.01 |
P/E | 291.74 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -8065.31% |
Dividend | - | Sales Q/Q | - |
Insider Own | 46.44% | Inst Own | 0.01% |
Insider Trans | 0.00% | Inst Trans | -0.21% |
Short Float | 0.04% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 41.71K | 52W Range | 3.40 - 14.00 |
|
|
|
Graphjet Technology engages in the manufacture of artificial graphene and graphite, a critical raw material used in a variety of industries, such as biomedical, automobile composition and coating, electronics and home appliances, food and beverage processing, energy storage, batteries in electric vehicles, mechanical strength enhancement, sensors, semiconductors, and digital products. The company is headquartered in Kuala Lumpur, Malaysia. |
|
| ![](gfx/nic2x2.gif) |
![RKDA - Arcadia Biosciences Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=RKDA&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 1.65M | EPS (ttm) | -5.29 |
P/E | - | EPS this Y | 91.87% |
Forward P/E | - | EPS next Y | -34.20% |
PEG | - | EPS past 5Y | 39.82% |
P/S | 0.30 | EPS next 5Y | 14.96% |
P/B | 0.34 | EPS Q/Q | 83.61% |
Dividend | - | Sales Q/Q | -16.83% |
Insider Own | 2.63% | Inst Own | 6.60% |
Insider Trans | 4.49% | Inst Trans | - |
Short Float | 9.33% | Earnings | May 09/a |
Analyst Recom | 1.00 | Target Price | 9.00 |
Avg Volume | 23.51K | 52W Range | 1.85 - 5.20 |
|
|
|
Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Schaefer Thomas J. | Chief Financial Officer | Feb 01 '24 | Buy | 2.06 | 700 | 1,442 | 1,419 | Feb 05 04:29 PM | Schaefer Thomas J. | Chief Financial Officer | Aug 04 '23 | Buy | 3.67 | 649 | 2,382 | 719 | Aug 07 07:55 PM |
|
|
![](gfx/nic2x2.gif) |
![IRTC - iRhythm Technologies Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=IRTC&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 2.75B | EPS (ttm) | -4.22 |
P/E | - | EPS this Y | 21.03% |
Forward P/E | - | EPS next Y | 38.53% |
PEG | - | EPS past 5Y | -13.90% |
P/S | 5.35 | EPS next 5Y | - |
P/B | 30.43 | EPS Q/Q | -14.01% |
Dividend | - | Sales Q/Q | 18.39% |
Insider Own | 1.74% | Inst Own | 111.70% |
Insider Trans | -8.79% | Inst Trans | 0.44% |
Short Float | 9.49% | Earnings | Aug 01/a |
Analyst Recom | 1.08 | Target Price | 132.64 |
Avg Volume | 375.68K | 52W Range | 70.24 - 124.11 |
|
|
|
iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Turakhia Minang | EVP, CMO & CSO | Jul 02 '24 | Sale | 105.65 | 1,404 | 148,333 | 27,255 | Jul 03 03:35 PM | Shrishrimal Sumi | EVP, Chief Risk Officer | Jun 03 '24 | Sale | 88.91 | 1,131 | 100,557 | 23,298 | Jun 05 12:40 PM | Rosenbaum Marc W. | Chief Accounting Officer | Jun 03 '24 | Sale | 88.91 | 510 | 45,344 | 8,174 | Jun 05 12:40 PM | Blackford Quentin S. | President and CEO | Mar 04 '24 | Sale | 111.14 | 4,221 | 469,122 | 175,794 | Mar 05 04:52 PM | Day Mark J. | Chief Technology Officer | Mar 04 '24 | Sale | 111.14 | 3,248 | 360,983 | 61,164 | Mar 05 04:53 PM |
|
|
| ![](gfx/nic2x2.gif) |
![LTRY - Lottery.com Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=LTRY&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 5.45M | EPS (ttm) | -10.01 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -91.59% |
P/S | 0.82 | EPS next 5Y | - |
P/B | 0.17 | EPS Q/Q | -14.18% |
Dividend | - | Sales Q/Q | -58.19% |
Insider Own | 11.63% | Inst Own | 6.06% |
Insider Trans | 0.00% | Inst Trans | 139.07% |
Short Float | 9.27% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 280.00 |
Avg Volume | 126.31K | 52W Range | 0.82 - 13.00 |
|
|
|
Lottery.com, Inc. engages in the provision of domestic and international lottery products and services. As an independent third-party lottery game service, it develops and operates a platform which enables the remote purchase of legally sanctioned lottery games. The company was founded by Lawrence Anthony DiMatteo III and Matthew Allen Clemenson on March 17,2016 and is headquartered in Spicewood, TX. |
|
![](gfx/nic2x2.gif) |
![INSP - Inspire Medical Systems Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=INSP&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 3.74B | EPS (ttm) | -0.55 |
P/E | - | EPS this Y | 122.19% |
Forward P/E | 158.82 | EPS next Y | 395.78% |
PEG | - | EPS past 5Y | 13.57% |
P/S | 5.65 | EPS next 5Y | 64.60% |
P/B | 6.34 | EPS Q/Q | 36.29% |
Dividend | - | Sales Q/Q | 28.24% |
Insider Own | 2.13% | Inst Own | 110.37% |
Insider Trans | -11.91% | Inst Trans | 2.60% |
Short Float | 4.97% | Earnings | Aug 06/a |
Analyst Recom | 1.75 | Target Price | 230.19 |
Avg Volume | 646.93K | 52W Range | 123.27 - 293.63 |
|
|
|
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
McCormick Shawn | Director | May 10 '24 | Option Exercise | 0.94 | 2,500 | 2,350 | 15,403 | May 13 04:30 PM | NELSON MARILYN C | Director | Apr 29 '24 | Option Exercise | 240.68 | 1,175 | 282,799 | 35,620 | May 01 04:01 PM | Buchholz Richard | Chief Financial Officer | Apr 17 '24 | Sale | 230.03 | 15,000 | 3,450,450 | 28,271 | Apr 18 04:44 PM | NELSON MARILYN C | Director | Apr 01 '24 | Option Exercise | 16.00 | 3,273 | 52,368 | 34,338 | Apr 02 08:29 PM | Griffin Jerry C | Director | Apr 01 '24 | Option Exercise | 16.00 | 296 | 4,736 | 10,932 | Apr 03 04:55 PM |
|
|
| ![](gfx/nic2x2.gif) |
![BFRG - Bullfrog AI Holdings Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=BFRG&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 23.55M | EPS (ttm) | -0.92 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 336.43 | EPS next 5Y | - |
P/B | 3.46 | EPS Q/Q | 5.91% |
Dividend | - | Sales Q/Q | - |
Insider Own | 58.13% | Inst Own | 2.34% |
Insider Trans | -2.14% | Inst Trans | - |
Short Float | 13.45% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 195.36K | 52W Range | 1.43 - 8.35 |
|
|
|
BullFrog AI Holdings, Inc. is a digital biopharmaceutical company, which engages in artificial intelligence and machine learning driven analysis of complex data sets in medicine and healthcare. The company was founded by Vininder Singh in August 2017 and is headquartered in Gaithersburg, MD. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Singh Vininder | Chief Executive Officer | Jul 09 '24 | Sale | 1.59 | 11,751 | 18,719 | 2,492,446 | Jul 09 05:15 PM | Singh Vininder | Chief Executive Officer | Jul 08 '24 | Sale | 1.47 | 10,670 | 15,689 | 2,504,197 | Jul 09 05:15 PM | Singh Vininder | Chief Executive Officer | Jul 05 '24 | Sale | 1.58 | 7,095 | 11,209 | 2,514,867 | Jul 09 05:15 PM | Singh Vininder | Chief Executive Officer | Jul 03 '24 | Sale | 1.66 | 2,757 | 4,580 | 2,521,962 | Jul 03 04:30 PM | Singh Vininder | Chief Executive Officer | Jul 02 '24 | Sale | 1.67 | 3,808 | 6,344 | 2,524,719 | Jul 03 04:30 PM |
|
|
![](gfx/nic2x2.gif) |
![LGCL - Lucas GC Ltd - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=LGCL&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 195.10M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 88.43% | Inst Own | 0.29% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.64% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 394.45K | 52W Range | 1.88 - 5.00 |
|
|
|
Lucas GC Ltd. engages in providing recruitment and outsourcing services through its subsidiaries The company was founded by Howard Lee on August 15, 2022 and is headquartered in Beijing, China. |
|
![](gfx/nic2x2.gif) |
![CNTM - ConnectM Technology Solutions Inc. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=CNTM&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 10.49M | EPS (ttm) | -2.26 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.27 | EPS Q/Q | -1878.93% |
Dividend | - | Sales Q/Q | - |
Insider Own | 70.92% | Inst Own | 73.80% |
Insider Trans | 0.00% | Inst Trans | 79.24% |
Short Float | 0.24% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 295.25K | 52W Range | 0.99 - 12.47 |
|
|
|
Connectm Technology Solutions, Inc. is a clean energy technology and solutions provider for residential and light commercial buildings and all-electric original equipment manufacturers, or OEMs, with a proprietary digital platform to accelerate the transition to solar and all-electric heating, cooling, and transportation. The company is headquartered in Marlborough, MA. |
|
|